Curie Co. Inc.
New York, NY · Founded 2017 · CIK 0001792122 · Biotech · Private
pH-responsive immobilized enzyme platform for continuous biopharmaceutical manufacturing
curieco.com →- Grants
- $1.4M
- 2 awards
- Sector median: 1
- Raised
- $13M
- 3 Form D · Jan 2022
- 57 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 36
- 2 granted · 34 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Reducing the cost of biomanufacturing and biopharmaceutical production with smart biocatalysts that can be incorporated into continuous processing technologies | $225,000 | |
| Private capital raised | Form D · SEC | $775,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Production of Biocidal Enzymes for Antimicrobial Applications | $1,199,999 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $12,110,522 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2480 | MANHATTAN PHARMACEUTICALS INC | — | $14M |
| 2481 | CORNERSTONE PHARMACEUTICALS INC | — | $13M |
| 2482 | DMC Limited | — | — |
| 2483 | Curie Co. Inc. | — | $13M |
| 2484 | Incannex Healthcare Inc. | — | $12M |
| 2485 | Genialis, Inc. | — | $12M |
| 2486 | Borealis Biosciences | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Erika MilczekDirector · Executive Officer
Patents
- Immobilized Proteases For Activation Of The Zymogen Form Of Transglutaminasegranted
- Pro-peptide Variants For Modulating Activity Of Transglutaminasesapplication
- Antimicrobial Compositionsapplication
- Preservative Compositions and Methods of Use Thereofapplication
- Preservative Compositions and Methods of Use Thereofgranted
- Sunscreen Compositions Comprising Imine Analogs Of A Sunscreen Comprising A Ketoneapplication
- Immobilized Proteases For Activation Of The Zymogen Form Of Transglutaminaseapplication
- Compositions And Methods Of Use Thereofapplication
- Transglutaminase Variants And Applications Of Use Thereofapplication
- Transglutaminase Variantsapplication
- Methods For Cell Free Protein Expression Of Mature Polypeptides Derived From Zymogens And Proproteinsapplication
- Sunscreen Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.